Cancer Research Donn Young  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Avogadri, F.
Right arrow Articles by Rescigno, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Avogadri, F.
Right arrow Articles by Rescigno, M.
[Cancer Research 65, 3920-3927, May 1, 2005]
© 2005 American Association for Cancer Research


Immunology

Cancer Immunotherapy Based on Killing of Salmonella-Infected Tumor Cells

Francesca Avogadri1, Chiara Martinoli1, Liljana Petrovska4, Claudia Chiodoni2, Pietro Transidico1, Vincenzo Bronte5, Renato Longhi3, Mario P. Colombo2, Gordon Dougan4 and Maria Rescigno1

1 Department of Experimental Oncology, European Institute of Oncology; 2 Immunotherapy and Gene Therapy Unit, Istituto Nazionale dei Tumori; 3 Istituto di Chimica del riconoscimento molecolare, Consiglio Nazionale delle Ricerche, Milan, Italy; 4 Centre for Molecular Microbiology and Infection, Department of Biological Sciences, Imperial College London, London, United Kingdom; and 5 Department of Oncology and Surgical Sciences, University of Padova, Padova, Italy

Requests for reprints: Maria Rescigno, Department of Experimental Oncology, European Institute of Oncology, Via Ripamonti, 435, 20141 Milano, Italy. Phone: 39-02-57489925; Fax: 39-02-57489851; E-mail: maria.rescigno{at}ieo-ifom-campus.it.

A major obstacle for the development of effective immunotherapy is the ability of tumors to escape the immune system. The possibility to kill tumor cells because they are recognized as infected rather than as malignant could help overcome immune escape mechanisms. Here we report a conceptually new approach of cancer immunotherapy based on in vivo infection of tumors and killing of infected tumor cells. Attenuated but still invasive, Salmonella typhimurium can be successfully exploited to invade melanoma cells that can present antigenic determinants of bacterial origin and become targets for anti-Salmonella–specific T cells. However, to fully appreciate the anticancer therapeutic properties of S. typhimurium, tumor-bearing mice need to be vaccinated against S. typhimurium before intratumoral Salmonella injection. Tumor infection when coupled to anti-Salmonella vaccination leads to 50% to 100% tumor-free mice with a better outcome on larger tumors. Invasive Salmonella also exert an indirect toxic effect on tumor cells through the recruitment of inflammatory cells and the cross-presentation of tumor antigens, which allow induction of tumor-specific immune response. This is effective in retarding the growth of untreated established distant tumors and in protecting the mice from subsequent tumor challenges.




This article has been cited by other articles:


Home page
MicrobiologyHome page
A. Bishop, D. House, T. Perkins, S. Baker, R. A. Kingsley, and G. Dougan
Interaction of Salmonella enterica serovar Typhi with cultured epithelial cells: roles of surface structures in adhesion and invasion
Microbiology, July 1, 2008; 154(7): 1914 - 1926.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. Friedlos, P. Lehouritis, L. Ogilvie, D. Hedley, L. Davies, D. Bermudes, I. King, J. Martin, R. Marais, and C. J. Springer
Attenuated Salmonella Targets Prodrug Activating Enzyme Carboxypeptidase G2 to Mouse Melanoma and Human Breast and Colon Carcinomas for Effective Suicide Gene Therapy
Clin. Cancer Res., July 1, 2008; 14(13): 4259 - 4266.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Arrach, M. Zhao, S. Porwollik, R. M. Hoffman, and M. McClelland
Salmonella Promoters Preferentially Activated Inside Tumors
Cancer Res., June 15, 2008; 68(12): 4827 - 4832.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Gauvrit, S. Brandler, C. Sapede-Peroz, N. Boisgerault, F. Tangy, and M. Gregoire
Measles Virus Induces Oncolysis of Mesothelioma Cells and Allows Dendritic Cells to Cross-Prime Tumor-Specific CD8 Response
Cancer Res., June 15, 2008; 68(12): 4882 - 4892.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Huang, J. Zhao, S. Shen, H. Li, K.-L. He, G.-X. Shen, L. Mayer, J. Unkeless, D. Li, Y. Yuan, et al.
Listeria monocytogenes Promotes Tumor Growth via Tumor Cell Toll-Like Receptor 2 Signaling
Cancer Res., May 1, 2007; 67(9): 4346 - 4352.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Chieppa, M. Rescigno, A. Y.C. Huang, and R. N. Germain
Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement
J. Exp. Med., December 25, 2006; 203(13): 2841 - 2852.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.